Search

everythinglearnresearchcommunity

for

Search:↓

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Clascoterone is safe for the heart, even at high doses.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

Costunolide helps human hair cells grow and can stimulate hair growth in mice.

Calancardin B may help reduce inflammation in immune cells.

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.

Diphenylcyclopropenone topical immunotherapy is effective for treating alopecia areata, with some side effects.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

The document concludes that scientists created various steroids with different properties, including a more effective semi-synthetic vitamin D.

A form of vitamin E promotes hair growth by activating a specific skin pathway.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

A new molecule was found to be a safe and effective skin lightener and anti-aging product.